ArticleThe Korean journal of internal medicine2017

KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer.

Sehhoon Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.